Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has shared an update.
WuXi AppTec Co., Ltd. has proposed an increase in its registered capital following the conversion of its outstanding U.S.$500 million zero coupon guaranteed convertible bonds due 2025 into H shares. The company’s total share capital would rise from 2,951,506,736 to 2,983,757,155 shares, reflecting the issuance of 32,250,419 additional H shares and lifting the H-share count to 510,476,909.
To align its corporate governance framework with the enlarged capital base, WuXi AppTec plans to amend its Articles of Association to update the registered capital and shareholding structure. These changes, along with an authorization for the board and chairman to handle related registration and filing matters, will be put to shareholders for approval as special resolutions at the forthcoming annual general meeting, signaling incremental dilution but also progress in executing its prior financing strategy.
The most recent analyst rating on (HK:2359) stock is a Hold with a HK$124.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a China-based contract research, development and manufacturing organization serving the global pharmaceutical and biotech industries. The company operates through A shares and H shares in the capital markets, providing integrated services that support drug discovery, development and production for international healthcare customers.
Average Trading Volume: 4,883,675
Technical Sentiment Signal: Buy
Current Market Cap: HK$303.7B
See more insights into 2359 stock on TipRanks’ Stock Analysis page.